InvestorsHub Logo
Followers 53
Posts 1783
Boards Moderated 0
Alias Born 03/22/2015

Re: None

Wednesday, 07/15/2015 9:02:10 PM

Wednesday, July 15, 2015 9:02:10 PM

Post# of 403141
I love it when he talks that way.


Nasrat Hakim:

...I’ve said this before, I have more than a dozen ideas of our stock that are ready to go into clinical trials and into the market. We don’t have to mind or to execute all of them, so when we decide which are the cream of the top, the top two, three or four and focus on these, keeping in mind how much they’re going to cost..






You do not sell a $1 billion technology for one product’s price.





1. ELI-200
Only True Abuse-Deterrent Immediate-Release Opioid
>90% opioid prescriptions are for immediate-release opioids
End of Phase 3 next few weeks
FDA "Priority Review"
Epic Milestone Payments

2. ELI-201
Pharm-based ADF 12 HR Oxycodone
$2.7 Billion OxyContin Market

3. ELI-216
Pharm-based ADF 24 HR Oxycodone
Only 24-hour Oxycodone

4. ?????????
2 bead Pharm-based ADF
Immediate vs. controlled release?
Morphine, Hydrocodone, Oxymorphone, Hydromorphone?

"There are three kinds of lies: lies, damned lies, and statistics."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News